Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 1472 | 7159 | 33.8 | 73% |
Classes in level above (level 3) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 385 | 29018 | ANTIPHOSPHOLIPID SYNDROME//SYSTEMIC LUPUS ERYTHEMATOSUS//ANTIPHOSPHOLIPID ANTIBODIES |
Classes in level below (level 1) |
| ID, lev. below | Publications | Label for level below |
|---|---|---|
| 609 | 3164 | LUPUS NEPHRITIS//SYSTEMIC LUPUS ERYTHEMATOSUS//LUPUS |
| 5529 | 1545 | NEUROPSYCHIATRIC LUPUS//NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS//NEUROPSYCHIATRIC SLE |
| 8106 | 1218 | LIBMAN SACKS ENDOCARDITIS//LUPUS MYOCARDITIS//LUPUS CLIN |
| 14981 | 669 | INTESTINAL LYMPHANGIECTASIA//LUPUS ENTERITIS//PROTEIN LOSING ENTEROPATHY |
| 20784 | 385 | CRA DIP//SECC INMUNOGENET//SERV ATENDIMENTO ESPECIALIZADO SMS BELFORD ROXO |
| 27947 | 178 | JACCOUDS ARTHROPATHY//RHUPUS//DEFORMING ARTHROPATHY |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | SYSTEMIC LUPUS ERYTHEMATOSUS | Author keyword | 662 | 25% | 32% | 2268 |
| 2 | LUPUS | Journal | 304 | 27% | 13% | 950 |
| 3 | LUPUS NEPHRITIS | Author keyword | 247 | 37% | 7% | 532 |
| 4 | SLE | Author keyword | 101 | 21% | 6% | 420 |
| 5 | NEUROPSYCHIATRIC LUPUS | Author keyword | 83 | 67% | 1% | 75 |
| 6 | NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS | Author keyword | 60 | 80% | 1% | 37 |
| 7 | LUPUS CLIN | Address | 57 | 64% | 1% | 56 |
| 8 | NEUROPSYCHIATRIC SLE | Author keyword | 53 | 89% | 0% | 24 |
| 9 | JACCOUDS ARTHROPATHY | Author keyword | 44 | 85% | 0% | 23 |
| 10 | NPSLE | Author keyword | 35 | 89% | 0% | 16 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | SYSTEMIC LUPUS ERYTHEMATOSUS | 662 | 25% | 32% | 2268 | Search SYSTEMIC+LUPUS+ERYTHEMATOSUS | Search SYSTEMIC+LUPUS+ERYTHEMATOSUS |
| 2 | LUPUS NEPHRITIS | 247 | 37% | 7% | 532 | Search LUPUS+NEPHRITIS | Search LUPUS+NEPHRITIS |
| 3 | SLE | 101 | 21% | 6% | 420 | Search SLE | Search SLE |
| 4 | NEUROPSYCHIATRIC LUPUS | 83 | 67% | 1% | 75 | Search NEUROPSYCHIATRIC+LUPUS | Search NEUROPSYCHIATRIC+LUPUS |
| 5 | LUPUS | 81 | 22% | 4% | 322 | Search LUPUS | Search LUPUS |
| 6 | NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS | 60 | 80% | 1% | 37 | Search NEUROPSYCHIATRIC+SYSTEMIC+LUPUS+ERYTHEMATOSUS | Search NEUROPSYCHIATRIC+SYSTEMIC+LUPUS+ERYTHEMATOSUS |
| 7 | NEUROPSYCHIATRIC SLE | 53 | 89% | 0% | 24 | Search NEUROPSYCHIATRIC+SLE | Search NEUROPSYCHIATRIC+SLE |
| 8 | JACCOUDS ARTHROPATHY | 44 | 85% | 0% | 23 | Search JACCOUDS+ARTHROPATHY | Search JACCOUDS+ARTHROPATHY |
| 9 | NPSLE | 35 | 89% | 0% | 16 | Search NPSLE | Search NPSLE |
| 10 | ANTI RIBOSOMAL P | 33 | 100% | 0% | 13 | Search ANTI+RIBOSOMAL+P | Search ANTI+RIBOSOMAL+P |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ERYTHEMATOSUS | 344 | 28% | 15% | 1047 |
| 2 | INTRAVENOUS CYCLOPHOSPHAMIDE | 200 | 52% | 4% | 272 |
| 3 | NEUROPSYCHIATRIC LUPUS | 194 | 76% | 2% | 136 |
| 4 | NEUROPSYCHIATRIC MANIFESTATIONS | 191 | 74% | 2% | 141 |
| 5 | 3 ETHNIC GROUPS | 166 | 61% | 2% | 176 |
| 6 | RHEUMATOLOGY DAMAGE INDEX | 110 | 79% | 1% | 71 |
| 7 | NEPHRITIS | 106 | 16% | 8% | 587 |
| 8 | PULSE CYCLOPHOSPHAMIDE | 104 | 45% | 2% | 172 |
| 9 | MULTIETHNIC US COHORT | 100 | 77% | 1% | 69 |
| 10 | REVISED CRITERIA | 93 | 19% | 6% | 434 |
Journals |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | LUPUS | 304 | 27% | 13% | 950 |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Brain abnormalities in newly diagnosed neuropsychiatric lupus: Systematic MRI approach and correlation with clinical and laboratory data in a large multicenter cohort | 2015 | 4 | 42 | 83% |
| A volcanic explosion of autoantibodies in systemic lupus erythematosus: A diversity of 180 different antibodies found in SLE patients | 2015 | 5 | 41 | 56% |
| Patterns of systemic lupus erythematosus expression in Europe | 2014 | 17 | 41 | 90% |
| Understanding the Epidemiology and Progression of Systemic Lupus Erythematosus | 2010 | 131 | 112 | 89% |
| Diagnosis and management of neuropsychiatric SLE | 2014 | 16 | 101 | 85% |
| Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis | 2012 | 102 | 162 | 59% |
| Optimizing outcome in SLE: treating-to-target and definition of treatment goals | 2014 | 12 | 92 | 86% |
| Treat-to-target in systemic lupus erythematosus: recommendations from an international task force | 2014 | 14 | 114 | 71% |
| Treatment of severe lupus nephritis: the new horizon | 2015 | 2 | 157 | 66% |
| EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs | 2010 | 101 | 83 | 67% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | LUPUS CLIN | 57 | 64% | 0.8% | 56 |
| 2 | PROGNOSIS STUDIES RHEUMAT DIS | 35 | 34% | 1.2% | 84 |
| 3 | SECT TRAUMA BURNS CRIT CARE | 26 | 69% | 0.3% | 22 |
| 4 | CEDARS SINAI DAVID GEFFEN MED | 18 | 83% | 0.1% | 10 |
| 5 | LUPUS UNIT | 12 | 18% | 0.8% | 59 |
| 6 | LANARKSHIRE RHEUMATOL | 12 | 86% | 0.1% | 6 |
| 7 | HLTH CARE OUTCOME | 9 | 67% | 0.1% | 8 |
| 8 | AUTOIMMUNE DIS | 9 | 10% | 1.1% | 81 |
| 9 | WILLIAM ROWE RHEUMATOL | 8 | 56% | 0.1% | 10 |
| 10 | ASSESSMENT TREATMENT RHEUMAT DIS | 6 | 80% | 0.1% | 4 |
Related classes at same level (level 2) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000034055 | ANTIPHOSPHOLIPID SYNDROME//ANTIPHOSPHOLIPID ANTIBODIES//LUPUS ANTICOAGULANT |
| 2 | 0.0000028794 | CONGENITAL HEART BLOCK//NEONATAL LUPUS//NEONATAL LUPUS ERYTHEMATOSUS |
| 3 | 0.0000008621 | WEGENERS GRANULOMATOSIS//GIANT CELL ARTERITIS//VASCULITIS |
| 4 | 0.0000008447 | CD40//BAFF//CD40 LIGAND |
| 5 | 0.0000008124 | RHEUMATOID ARTHRITIS//RHEUMATOLOGY//RHEUMATOL |
| 6 | 0.0000007985 | ARTHRITIS CARE AND RESEARCH//ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH//HEALTH ASSESSMENT QUESTIONNAIRE |
| 7 | 0.0000006319 | INTERLEUKIN 10//IL 1RN//INTERLEUKIN 1 BETA GENE |
| 8 | 0.0000006043 | DERMATOMYOSITIS//POLYMYOSITIS//INCLUSION BODY MYOSITIS |
| 9 | 0.0000005933 | PROLACTIN//PROLACTIN RECEPTOR//PHOSPHORYLATED PROLACTIN |
| 10 | 0.0000005890 | LDL APHERESIS//LOW DENSITY LIPOPROTEIN APHERESIS//APHERESIS |